Shekhar Krishnan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Oxide Nanoparticles

Respiratory Failure

Top Venues

Pediatric blood & cancer

Journal of pediatric hematology/oncology

Indian journal of pediatrics

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anindita Dutta, Tushar Mungle, Nandita Chowdhury, Pritha Banerjee, Anisha Gehani, Saugata Sen, Mohandas Mallath, Paromita Roy, Shekhar Krishnan, Sandip Ganguly, Sudeep Banerjee, Manas Roy, Vaskar Saha
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019. Cancer medicine (2023)
Tushar Mungle, Ananya Mahadevan, Parag Das, Amit K Mehta, Manash P Gogoi, Bishwaranjan Jana, Niharendu Ghara, Debjani Ghosh, Vaskar Saha, Shekhar Krishnan
Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia. Journal of pediatric hematology/oncology (2023)
Shekhar Krishnan, Ananya Mahadevan, Tushar Mungle, Manash Pratim Gogoi, Vaskar Saha
Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer. Indian journal of pediatrics (2023)
Jasmeet Sidhu, Ashish Narayan Masurekar, Manash Pratim Gogoi, Caroline Fong, Tasos Ioannou, Taha Lodhi, Catriona Parker, Jizhong Liu, Amy A Kirkwood, Anthony V Moorman, Kiranmoy Das, Nicholas J Goulden, Ajay Vora, Vaskar Saha, Shekhar Krishnan
Activity and toxicity of intramuscular 1000 iu/m 2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials. British journal of haematology 198 (1) (2022)
Jasmeet Sidhu, Manash Pratim Gogoi, Praveen Agarwal, Tathagata Mukherjee, Debparna Saha, Priyanka Bose, Prakriti Roy, Yogesh Phadke, Bhatu Sonawane, Pritha Paul, Vaskar Saha, Shekhar Krishnan
Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia. Pediatric blood & cancer 68 (11) (2021)
Jasmeet Sidhu, Vaskar Saha, Shekhar Krishnan
Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India-Implications for clinical outcomes in acute lymphoblastic leukaemia. Pediatric blood & cancer (2021)